Patent: 10,105,423
✉ Email this page to a colleague
Summary for Patent: 10,105,423
| Title: | C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency |
| Abstract: | Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficiency are disclosed. |
| Inventor(s): | Stephen Ruddy, Mark Cornell Manning, Ryan Erik Holcomb |
| Assignee: | Viropharma Biologics LLC |
| Application Number: | US15/837,693 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,105,423
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | CINRYZE | c1 esterase inhibitor (human) | For Injection | 125267 | October 10, 2008 | 10,105,423 | 2037-12-11 |
| Csl Behring Gmbh | HAEGARDA | c1 esterase inhibitor subcutaneous (human) | For Injection | 125606 | June 22, 2017 | 10,105,423 | 2037-12-11 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,105,423
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201806793 | ⤷ Start Trial |
| South Africa | 201706929 | ⤷ Start Trial |
| South Africa | 201507604 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2014145519 | ⤷ Start Trial |
| United States of America | 9616111 | ⤷ Start Trial |
| United States of America | 2020261556 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
